Overview

  • Product name
    O-1602
  • Description
    Potent, selective GPR55 agonist
  • Biological description
    Analog of cannabidiol that is a potent agonist at the GPR55 cannabinoid receptor (EC50 values are 13, >30000 and >30000 nM for GPR55, CB1 and CB2 receptors, respectively). Inhibits mouse osteoclast formation in vitro, stimulates osteoclast polarization and resorption, causes activation of Rho and ERK1/2, and inhibits human neutrophil migration.
  • Purity
    > 98%
  • General notes
    Sold under license from Virginia Commonwealth University.

Properties

References

This product has been referenced in:
  • Whyte LS  et al. The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc Natl Acad Sci U S A 106:16511-6 (2009). Read more (PubMed: 19805329) »
  • McHugh D  et al. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. Mol Pharmacol 73:441-50 (2008). Read more (PubMed: 17965195) »
  • Ryberg E  et al. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152:1092-101 (2007). Read more (PubMed: 17876302) »

See 1 Publication for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab120407.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up